EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2

Cara O'Mahoney, Ian Watt, Sebastian Fiedler, Sean Devenish, Sujata Srikanth, Erica Justice, Tristan Dover, Delphine Dean, Congyue Peng

Annals of Biomedical Engineering · 2024

DOI: 10.1007/s10439-024-03478-0 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Biomedical Engineering, 2024. Verfasst von Cara O'Mahoney und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Bioengineering, Clemson University, Clemson, SC, USA. Hauptthemen laut MEDLINE: Antibodies, Neutralizing, SARS-CoV-2, Spike Glycoprotein, Coronavirus, Angiotensin-Converting Enzyme 2. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clemson University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

SARS-CoV-2 has rampantly spread around the globe and continues to cause unprecedented loss through ongoing waves of (re)infection. Increasing our understanding of the protection against infection with SARS-CoV-2 is critical to ending the pandemic. Serological assays have been widely used to assess immune responses, but secretory antibodies, the essential first line of defense, have been studied to only a limited extent. Of particular interest and importance are neutralizing antibodies, which block the binding of the spike protein of SARS-CoV-2 to the human receptor angiotensin-converting enzyme-2 (ACE2) and thus are essential for immune defense. Here, we employed Microfluidic Diffusional Sizing (MDS), an immobilization-free technology, to characterize neutralizing antibody affinity to SARS-CoV-2 spike receptor-binding domain (RBD) and spike trimer in saliva. Affinity measurement was obtained through a contrived sample and buffer using recombinant SARS-CoV-2 RBD and monoclonal antibody. Limited saliva samples demonstrated that MDS applies to saliva neutralizing antibody measurement. The ability to disrupt a complex of ACE2-Fc and spike trimer is shown. Using a quantitative assay on the patient sample, we determined the affinity and binding site concentration of the neutralizing antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, NeutralizingSARS-CoV-2Spike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2COVID-19Antibodies, ViralHumansSalivaAntibody AffinityAntibodies, Monoclonal

Stichwörter der Autor:innen

Microfluidic diffusional sizingNeutralizing antibodySARS-CoV-2Saliva

Substanzen

Antibodies, NeutralizingSpike Glycoprotein, CoronavirusAngiotensin-Converting Enzyme 2spike protein, SARS-CoV-2Antibodies, ViralACE2 protein, humanAntibodies, Monoclonal

Autor:innen und Institutionen

  • Department of Bioengineering, Clemson University, Clemson, SC, USA.
  • Fluidic Analytics, Cambridge, UK.
  • Center for Innovative Medical Devices and Sensors, Clemson University, Clemson, SC, USA.
  • Department of Bioengineering, Clemson University, Clemson, SC, USA. congyup@clemson.edu.
  • Center for Innovative Medical Devices and Sensors, Clemson University, Clemson, SC, USA. congyup@clemson.edu.

Förderung

  • Clemson University

Zitieren

APA

O'Mahoney, C., Watt, I., Fiedler, S., Devenish, S., Srikanth, S., Justice, E., Dover, T., Dean, D., & Peng, C. (2024). Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2. Annals of Biomedical Engineering. https://doi.org/10.1007/s10439-024-03478-0

Vancouver

O'Mahoney C, Watt I, Fiedler S, Devenish S, Srikanth S, Justice E, et al. Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2. Annals of Biomedical Engineering. 2024. doi:10.1007/s10439-024-03478-0

BibTeX
@article{OMahoney2024,
  author = {O'Mahoney, Cara and Watt, Ian and Fiedler, Sebastian and Devenish, Sean and Srikanth, Sujata and Justice, Erica and Dover, Tristan and Dean, Delphine and Peng, Congyue},
  title = {Microfluidic Diffusional Sizing (MDS) Measurements of Secretory Neutralizing Antibody Affinity Against SARS-CoV-2},
  journal = {Annals of Biomedical Engineering},
  year = {2024},
  doi = {10.1007/s10439-024-03478-0}
}
Kostenlos starten →